US OptionsDetailed Quotes
DG241004P92000
- 6.04
- 0.000.00%
15min DelayTrading Sep 23 15:32 ET
0.00High0.00Low
0.00Open6.04Pre Close0 Volume0 Open Interest92.00Strike Price0.00Turnover0.00%IV-1.92%PremiumOct 4, 2024Expiry Date7.66Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma11.17Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Dollar General Stock Discussion
Gapping up
$Bristol-Myers Squibb (BMY.US)$ Shares jumped 3.8% after the FDA approved Cobenfy as a new treatment for schizophrenia in adults, marking the first novel treatment for the mental disorder in several decades.
$Wynn Resorts (WYNN.US)$ Shares climbed 1.7% following an upgrade to overweight from equal weight by Morgan Stanley, which highlighted the company's strong fundamentals compared to its competitors...
No comment yet